The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

New research published in the American Journal of Health-System Pharmacy suggests a possible link between the GLP-1 drug ...

This Week’s Wellness Wednesday, we’re taking a look at a topic that crosses everyone’s mind, weight loss. There are many ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Doctors generally have an easier time diagnosing type 1 diabetes in kids, who present with classic symptoms of excessive thirst, excessive urination, and weight loss. “Children often have a really ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

Popular diabetes and weight loss drugs like Ozempic and Wegovy do not increase the risk of depression, anxiety or suicidal ideation, a new study finds.In fact, ...

When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

A woman who lost 55 pounds on Ozempic opens up about the most difficult side effect she faced—and shares simple tips that ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...